Literature DB >> 7430346

Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines.

C Benz, M Schoenberg, M Choti, E Cadman.   

Abstract

The effect of sequential methotrexate and 5-fluorouracil on the clonal growth of the human colon adenocarcinoma cell, HCT-8, and the hormone-dependent human breast carcinoma cell, 47-DN, was examined. In both cell lines, when 5-fluorouracil was given during the last 6 h of a 24 h methotrexate exposure period, there was marked synergistic inhibition of clonal growth. Shorter intervals or the reverse sequence of drugs were either additive or antagonistic. These results indicate the importance of the drug sequence and time interval between drug administration for optimal cytotoxicity in these human cell lines. This information suggests that the administration of methotrexate 18 h before 5-fluorouracil may have potential application in the design of clinical trials for these malignancies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430346      PMCID: PMC371555          DOI: 10.1172/JCI109946

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  Establishment and characterization of a cell line of human breast carcinoma origin.

Authors:  I Keydar; L Chen; S Karby; F R Weiss; J Delarea; M Radu; S Chaitcik; H J Brenner
Journal:  Eur J Cancer       Date:  1979-05       Impact factor: 9.162

2.  Enzyme kinetics and combination chemotherapy: an appraisal of current concepts.

Authors:  K R Harrap; R C Jackson
Journal:  Adv Enzyme Regul       Date:  1975

3.  Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum.

Authors:  W A Tompkins; A M Watrach; J D Schmale; R M Schultz; J A Harris
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

4.  Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil.

Authors:  J R Bertino; W L Sawicki; C A Lindquist; V S Gupta
Journal:  Cancer Res       Date:  1977-01       Impact factor: 12.701

5.  Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver.

Authors:  C K Carrico; R I Glazer
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

6.  Studies on a pyrimidine phosphoribosyltransferase from murine leukemia P1534J. Partial purification, substrate specificity, and evidence for its existence as a bifunctional complex with orotidine 5-phosphate decarboxylase.

Authors:  P Reyes; M E Guganig
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

7.  Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate.

Authors:  B Ullman; M Lee; D W Martin; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

8.  Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism.

Authors:  E Cadman; R Heimer; L Davis
Journal:  Science       Date:  1979-09-14       Impact factor: 47.728

9.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

  9 in total
  11 in total

1.  Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas.

Authors:  F M Balis; A Gillespie; J Belasco; G H Reaman; L J Ettinger; R F Murphy; K Doherty; S Jeffries; M E Horowitz; D G Poplack
Journal:  Invest New Drugs       Date:  1990-05       Impact factor: 3.850

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  The design of rational combination chemotherapy for cancer.

Authors:  E C Cadman
Journal:  West J Med       Date:  1984-06

4.  Sequential methotrexate (MTX) and 5-fluorouracil (FU) in human tumor xenografts.

Authors:  K Wayss; R Herrmann; J Mattern; M Volm
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

5.  A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer.

Authors:  L Panasci; J Ford; R Margolese
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Development of a new human breast cancer cell line Ia-270.

Authors:  P M Loh; G Clamon; J MacIndoe; M White; L Urdaneta; B Hukku; W D Peterson
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Phase II study of adriamycin with sequential methotrexate and 5-fluorouracil (AMF) in gastric carcinoma.

Authors:  J A Ajani; P Goudeau; B Levin; J S Faintuch; J L Abbruzzese; B M Boman; M D Kanojia
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.

Authors:  C Benz; M Choti; L Newcomer; E Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.

Authors:  L L Danhauser; R Heimer; E Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  Methotrexate and 5-fluorouracil in the treatment of squamous and other carcinomas of the head and neck.

Authors:  D J Stewart; J A Maroun; C Cripps; V Young; G Laframboise; J Gerin-Lajoie
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.